PHAXIAM Therapeutics S.A. Financial Liabilities
PHAXIAM Therapeutics S.A. had Financial Liabilities of EUR 11.75 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes
ifrs-full:FinancialLiabilities · last filed 2023-09-26
- 2023-06-30: Financial Liabilities 11.75M EUR.
- 2022-12-31: Financial Liabilities 10.11M EUR.
- 2022-06-30: Financial Liabilities 15.45M EUR.
- 2021-12-31: Financial Liabilities 15.40M EUR.
| Period end | Financial Liabilities |
|---|---|
| 2023-06-30 | 11.75M EUR 6-K · filed 2023-09-26 |
| 2022-12-31 | 10.11M EUR 20-F · filed 2023-03-28 |
| 2022-06-30 | 15.45M EUR 6-K · filed 2022-09-12 |
| 2021-12-31 | 15.40M EUR 20-F · filed 2023-03-28 |
| 2021-06-30 | 14.68M EUR 6-K · filed 2021-09-20 |
| 2020-12-31 | 16.64M EUR 20-F · filed 2023-03-28 |
| 2020-06-30 | 4.39M EUR 6-K · filed 2020-09-21 |
| 2019-12-31 | 1.42M EUR 20-F · filed 2022-04-27 |
| 2019-06-30 | 1.73M EUR 6-K · filed 2019-09-26 |
| 2018-12-31 | 2.02M EUR 20-F · filed 2021-03-08 |
| 2017-12-31 | 2.84M EUR 20-F · filed 2020-03-18 |
| 2016-12-31 | 2.87M EUR 20-F · filed 2019-03-29 |
| 2015-12-31 | 707.00K EUR 20-F/A · filed 2018-05-23 |